Pricing
Login
Home
Charts
Search
Watchlist
Products

Alembic Pharmaceuticals Ltd

APLLTD
₹1,040.95-0.82%20 Nov 2026
Reports
Pharma Formulations

Alembic Pharmaceuticals Ltd

APLLTD
₹1,040.95
-0.82%
20 Nov 2026
Ask AI
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
₹20,461Cr
Close
Close Price
₹1,040.95
Industry
Industry
Pharma Formulations
PE
Price To Earnings
24.25
PS
Price To Sales
2.41
Revenue
Revenue
₹8,477Cr
Rev Gr TTM
Revenue Growth TTM
19.68%
PAT Gr TTM
PAT Growth TTM
32.94%

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Revenue
RevenueCr
1,6311,5171,5621,6481,6931,7701,7111,9101,8761,8482,1502,603
Growth YoY
Revenue Growth YoY%
8.17.95.13.33.816.79.515.910.84.425.736.3
Expenses
ExpensesCr
1,3641,2571,3251,4091,4331,4981,4291,5941,5831,6201,8182,040
Operating Profit
Operating ProfitCr
266260237239260272281316294228332563
OPM
OPM%
16.317.115.214.515.415.416.416.515.612.315.421.6
Other Income
Other IncomeCr
33230101468-2921514
Interest Expense
Interest ExpenseCr
151113192225242423232838
Depreciation
DepreciationCr
6969697170697476808998101
PBT
PBTCr
185183157180178192190224162119222438
Tax
TaxCr
4522274035364030-8350104
PAT
PATCr
180178135153138157154184132202172334
Growth YoY
PAT Growth YoY%
48.016.811.612.1-23.7-12.114.220.0-4.228.712.281.8
NPM
NPM%
11.111.88.69.38.18.89.09.67.010.98.012.8
EPS
EPS₹
9.29.16.87.87.08.07.89.46.810.38.817.1
QuarterDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Revenue
RevenueCr
1,6311,5171,5621,6481,6931,7701,7111,9101,8761,8482,1502,603
Growth YoY
Revenue Growth YoY%
8.17.95.13.33.816.79.515.910.84.425.736.3
Expenses
ExpensesCr
1,3641,2571,3251,4091,4331,4981,4291,5941,5831,6201,8182,040
Operating Profit
Operating ProfitCr
266260237239260272281316294228332563
OPM
OPM%
16.317.115.214.515.415.416.416.515.612.315.421.6
Other Income
Other IncomeCr
33230101468-2921514
Interest Expense
Interest ExpenseCr
151113192225242423232838
Depreciation
DepreciationCr
6969697170697476808998101
PBT
PBTCr
185183157180178192190224162119222438
Tax
TaxCr
4522274035364030-8350104
PAT
PATCr
180178135153138157154184132202172334
Growth YoY
PAT Growth YoY%
48.016.811.612.1-23.7-12.114.220.0-4.228.712.281.8
NPM
NPM%
11.111.88.69.38.18.89.09.67.010.98.012.8
EPS
EPS₹
9.29.16.87.87.08.07.89.46.810.38.817.1

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
3,1663,1353,1313,9354,6065,3935,3065,6536,2296,6727,3458,477
Growth
Revenue Growth%
54.0-1.0-0.125.717.117.1-1.66.510.27.110.119.7
Expenses
ExpensesCr
2,1592,5192,4883,0613,3833,9134,4324,9445,2955,6646,2267,061
Operating Profit
Operating ProfitCr
1,0076156438741,2231,4808747089331,0081,1181,417
OPM
OPM%
31.819.620.522.226.627.416.512.515.015.115.216.7
Other Income
Other IncomeCr
7279-398756-282756-122
Interest Expense
Interest ExpenseCr
5531827161850567994112
Depreciation
DepreciationCr
7283105115157183287275273279319367
PBT
PBTCr
9365295417491,0001,368625355632707694940
Tax
TaxCr
216122120157199253104131612523100
PAT
PATCr
7204074215938011,115521342616582671840
Growth
PAT Growth%
154.7-43.53.440.835.139.2-53.3-34.480.1-5.515.332.9
NPM
NPM%
22.713.013.415.117.420.79.86.09.98.79.19.9
EPS
EPS₹
38.221.421.931.044.060.826.517.431.329.734.342.9
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
3,1663,1353,1313,9354,6065,3935,3065,6536,2296,6727,3458,477
Growth
Revenue Growth%
54.0-1.0-0.125.717.117.1-1.66.510.27.110.119.7
Expenses
ExpensesCr
2,1592,5192,4883,0613,3833,9134,4324,9445,2955,6646,2267,061
Operating Profit
Operating ProfitCr
1,0076156438741,2231,4808747089331,0081,1181,417
OPM
OPM%
31.819.620.522.226.627.416.512.515.015.115.216.7
Other Income
Other IncomeCr
7279-398756-282756-122
Interest Expense
Interest ExpenseCr
5531827161850567994112
Depreciation
DepreciationCr
7283105115157183287275273279319367
PBT
PBTCr
9365295417491,0001,368625355632707694940
Tax
TaxCr
216122120157199253104131612523100
PAT
PATCr
7204074215938011,115521342616582671840
Growth
PAT Growth%
154.7-43.53.440.835.139.2-53.3-34.480.1-5.515.332.9
NPM
NPM%
22.713.013.415.117.420.79.86.09.98.79.19.9
EPS
EPS₹
38.221.421.931.044.060.826.517.431.329.734.342.9
Sales CAGR
1 Year10%
3 Years9%
5 Years6%
TTM20%
EBITDA CAGR
1 Year11%
3 Years16%
5 Years-5%
TTM25%
PAT CAGR
1 Year15%
3 Years25%
5 Years-10%
TTM33%
Avg. ROCE
1 Year11%
3 Years12%
5 Years11%
TTM14%
CFO / EBITDA
1 Year70%
3 Years55%
5 Years64%
TTM-

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
383838383839393939393939
Reserves
ReservesCr
1,5601,8652,1822,6813,1825,0285,1984,3314,7795,1525,6365,905
Current Liabilities
Current LiabilitiesCr
7476931,1441,4901,7521,2811,7171,6371,4552,4122,5943,099
Non Current Liabilities
Non Current LiabilitiesCr
84945765701,047361168175172171500496
Total Liabilities
Total LiabilitiesCr
2,4292,6893,9414,7785,9896,7097,1226,1836,4467,7738,7639,531
Current Assets
Current AssetsCr
1,5111,3721,8251,9582,4632,6522,8612,9103,0794,0884,5435,253
Non Current Assets
Non Current AssetsCr
9171,3172,1162,8203,5264,0574,2613,2733,3673,6854,2204,278
Total Assets
Total AssetsCr
2,4292,6893,9414,7785,9896,7097,1226,1836,4467,7738,7639,531
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
383838383839393939393939
Reserves
ReservesCr
1,5601,8652,1822,6813,1825,0285,1984,3314,7795,1525,6365,905
Current Liabilities
Current LiabilitiesCr
7476931,1441,4901,7521,2811,7171,6371,4552,4122,5943,099
Non Current Liabilities
Non Current LiabilitiesCr
84945765701,047361168175172171500496
Total Liabilities
Total LiabilitiesCr
2,4292,6893,9414,7785,9896,7097,1226,1836,4467,7738,7639,531
Current Assets
Current AssetsCr
1,5111,3721,8251,9582,4632,6522,8612,9103,0794,0884,5435,253
Non Current Assets
Non Current AssetsCr
9171,3172,1162,8203,5264,0574,2613,2733,3673,6854,2204,278
Total Assets
Total AssetsCr
2,4292,6893,9414,7785,9896,7097,1226,1836,4467,7738,7639,531

Cash Flow

Consolidated
Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
9483293128124491,46355272480388783
Investing Cash Flow
Investing Cash FlowCr
-307-486-884-756-732-839-372-448-321-568-506
Financing Cash Flow
Financing Cash FlowCr
-224-12950359155-597-217-262-438444-164
Net Cash Flow
Net Cash FlowCr
417-286-69115-12827-371445-37113
Free Cash Flow
Free Cash FlowCr
948348-423159-285804128282487-466350
CFO To PAT
CFO To PAT%
131.680.774.2137.056.1131.3106.0211.7130.415.1116.7
CFO To EBITDA
CFO To EBITDA%
94.153.448.693.036.798.963.2102.286.08.770.0
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
9483293128124491,46355272480388783
Investing Cash Flow
Investing Cash FlowCr
-307-486-884-756-732-839-372-448-321-568-506
Financing Cash Flow
Financing Cash FlowCr
-224-12950359155-597-217-262-438444-164
Net Cash Flow
Net Cash FlowCr
417-286-69115-12827-371445-37113
Free Cash Flow
Free Cash FlowCr
948348-423159-285804128282487-466350
CFO To PAT
CFO To PAT%
131.680.774.2137.056.1131.3106.0211.7130.415.1116.7
CFO To EBITDA
CFO To EBITDA%
94.153.448.693.036.798.963.2102.286.08.770.0

Ratios

Consolidated
Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
11,32111,75610,36410,00110,05918,97114,5729,74919,30918,26613,01020,461
Price To Earnings
Price To Earnings
15.729.225.117.112.116.628.028.531.431.319.324.3
Price To Sales
Price To Sales
3.63.83.32.52.23.52.81.73.12.71.82.4
Price To Book
Price To Book
7.16.24.73.73.13.72.82.24.03.52.33.4
EV To EBITDA
EV To EBITDA
10.919.017.112.39.613.117.414.721.119.312.715.3
Profitability Ratios
Profitability Ratios
GPM
GPM%
66.463.562.866.468.168.064.360.463.864.064.264.2
OPM
OPM%
31.819.620.522.226.627.416.512.515.015.115.216.7
NPM
NPM%
22.713.013.415.117.420.79.86.09.98.79.19.9
ROCE
ROCE%
55.026.818.621.120.724.510.88.012.912.211.114.2
ROE
ROE%
45.121.419.021.824.922.09.97.812.811.211.814.1
ROA
ROA%
29.615.110.712.413.416.67.35.59.67.57.78.8
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
11,32111,75610,36410,00110,05918,97114,5729,74919,30918,26613,01020,461
Price To Earnings
Price To Earnings
15.729.225.117.112.116.628.028.531.431.319.324.3
Price To Sales
Price To Sales
3.63.83.32.52.23.52.81.73.12.71.82.4
Price To Book
Price To Book
7.16.24.73.73.13.72.82.24.03.52.33.4
EV To EBITDA
EV To EBITDA
10.919.017.112.39.613.117.414.721.119.312.715.3
Profitability Ratios
Profitability Ratios
GPM
GPM%
66.463.562.866.468.168.064.360.463.864.064.264.2
OPM
OPM%
31.819.620.522.226.627.416.512.515.015.115.216.7
NPM
NPM%
22.713.013.415.117.420.79.86.09.98.79.19.9
ROCE
ROCE%
55.026.818.621.120.724.510.88.012.912.211.114.2
ROE
ROE%
45.121.419.021.824.922.09.97.812.811.211.814.1
ROA
ROA%
29.615.110.712.413.416.67.35.59.67.57.78.8
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Market CapitalizationMkt CapCr35,49928,45122,44020,46118,27515,97415,424
Close PriceClose₹2,184.401,718.70822.651,040.951,317.20814.302,029.10
IndustryIndustryPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma Formulations
Price To EarningsPE86.5587.0728.4724.2525.6017.7422.38
Price To SalesPS9.4613.553.812.415.495.176.47
RevenueRevenueCr3,7512,1005,8958,4773,3303,0892,383
Revenue Growth TTMRev Gr TTM%25.7%46.3%21.8%19.7%11.1%-29.6%16.8%
PAT Growth TTMPAT Gr TTM%894.1%89.4%39.1%32.9%60.0%-56.4%17.4%
Market CapitalizationMkt CapCr35,49928,45122,44020,46118,27515,97415,424
Close PriceClose₹2,184.401,718.70822.651,040.951,317.20814.302,029.10
IndustryIndustryPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma Formulations
Price To EarningsPE86.5587.0728.4724.2525.6017.7422.38
Price To SalesPS9.4613.553.812.415.495.176.47
RevenueRevenueCr3,7512,1005,8958,4773,3303,0892,383
Revenue Growth TTMRev Gr TTM%25.7%46.3%21.8%19.7%11.1%-29.6%16.8%
PAT Growth TTMPAT Gr TTM%894.1%89.4%39.1%32.9%60.0%-56.4%17.4%
Interviews